U.S. Markets closed

Read This Before Selling Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Shares

Simply Wall St

We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So shareholders might well want to know whether insiders have been buying or selling shares in Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826).

What Is Insider Buying?

Most investors know that it is quite permissible for company leaders, such as directors of the board, to buy and sell stock in the company. However, most countries require that the company discloses such transactions to the market.

We would never suggest that investors should base their decisions solely on what the directors of a company have been doing. But it is perfectly logical to keep tabs on what insiders are doing. For example, a Columbia University study found that 'insiders are more likely to engage in open market purchases of their own company’s stock when the firm is about to reveal new agreements with customers and suppliers'.

View our latest analysis for Shanghai Haohai Biological Technology

The Last 12 Months Of Insider Transactions At Shanghai Haohai Biological Technology

There wasn't any very large single transaction over the last year, but we can still observe some trading.

Minjie Tang purchased 7000 shares over the year. The average price per share was HK$40.44. You can see a visual depiction of insider transactions (by individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

SEHK:6826 Recent Insider Trading, August 26th 2019

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Does Shanghai Haohai Biological Technology Boast High Insider Ownership?

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Shanghai Haohai Biological Technology insiders own 66% of the company, currently worth about HK$3.9b based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

What Might The Insider Transactions At Shanghai Haohai Biological Technology Tell Us?

It doesn't really mean much that no insider has traded Shanghai Haohai Biological Technology shares in the last quarter. But insiders have shown more of an appetite for the stock, over the last year. With high insider ownership and encouraging transactions, it seems like Shanghai Haohai Biological Technology insiders think the business has merit. Therefore, you should should definitely take a look at this FREE report showing analyst forecasts for Shanghai Haohai Biological Technology.

Of course Shanghai Haohai Biological Technology may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.